MSB 0.91% $1.11 mesoblast limited

Revascor

  1. 3,881 Posts.
    lightbulb Created with Sketch. 1318
    Revascor, four years in hibernation as Mesoblast sorted GVHD. Now the giant has snaped back into life.
    We have a meeting with the FDA booked for AA.
    CLBP P 3 trial underway.

    Wait on, " P3 trial underway " Is there a message there from the FDA. Did I see something about how the potancy assay had to be fit for commercial use before a P2 or P3 would be given the go ahead ?

    This is huge, we have a rulling , the FDA considers the Revascor potancy assay good to go. I would bet that the GVHD potancy assay is also good to go as SI stated that lessons from GVHD would be applyed to Revascor.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.